Error: Could not add to watchlist. X
+ Watchlist

Novogen Ltd

NVGN:US
NASDAQ CM
1.79
USD
0.07
4.07%
As of 8:10 PM EST 2/27/2017
Open
1.77
Day Range
1.67 - 1.88
Volume
113,586
Previous Close
1.72
52Wk Range
1.39 - 2.85
1 Yr Return
-7.73%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
1.77
Day Range
1.67 - 1.88
Volume
113,586
Previous Close
1.72
52Wk Range
1.39 - 2.85
1 Yr Return
-7.73%
YTD Return
22.18%
Current P/E Ratio (TTM)
-
Earnings per Share (AUD) (TTM)
-
Market Cap (m USD)
34.603
Shares Outstanding (m)
19.332
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.39%
% Price Change
+0.46%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Novogen Limited is a drug discovery company. The Company owns two proprietary drug technology platforms which include super-benzopyrans and anti-tropomyosins that target broad therapeutic potential across the fields of cancer, musculodegenerative diseases, neurodegenerative diseases, regenerative medicine, lysosomal storage diseases, and autoimmune diseases.
Address
16 - 20 Edgeworth David Ave
Hornsby, NSW 2077
Australia
Phone
61-2-9472-4100
Show More